Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
Introduction: The longevity of antibody levels against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major scientific interest. Antibody kinetics during the acute phase are well studied, whereas the long-term kinetics are yet to be de...
Main Authors: | Catharina Gerhards, Margot Thiaucourt, Maximilian Kittel, Celine Becker, Volker Ast, Michael Hetjens, Michael Neumaier, Verena Haselmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971221003921 |
Similar Items
-
Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
by: Maximilian Kittel, et al.
Published: (2021-02-01) -
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
by: Maurice Steenhuis, et al.
Published: (2021-01-01) -
Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
by: Maximilian Kittel, et al.
Published: (2021-04-01) -
Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial
by: F.W. Hamilton, et al.
Published: (2021-08-01) -
Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2
by: Xunyan Ye, et al.
Published: (2021-10-01)